| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.703 | 0.008 | 0.703 | Aldehyde oxidase inhibitor | 0.169 0.124 CID_154699678 | ||
| 0.665 | 0.004 | 0.665 | ErbB-1 antagonist | |||
| 0.617 | 0.005 | 0.617 | Src kinase inhibitor | |||
| 0.613 | 0.005 | 0.613 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.326 0.179 CID_154699678 | ||
| 0.618 | 0.01 | 0.618 | Tyrosine kinase inhibitor | |||
| 0.601 | 0.007 | 0.601 | GABA C receptor rho-3 antagonist | |||
| 0.559 | 0.018 | 0.559 | 5 Hydroxytryptamine release inhibitor | 0.381 0.091 CID_154699678 | ||
| 0.549 | 0.02 | 0.549 | 5 Hydroxytryptamine release stimulant | 0.171 0.151 CID_154699678 | ||
| 0.522 | 0.008 | 0.522 | Peroxidase inhibitor | 0.157 0.074 CID_154699678 | ||
| 0.554 | 0.044 | 0.554 | Caspase 9 stimulant | 0.365 0.134 CID_154699678 | ||
| 0.516 | 0.006 | 0.516 | EphB2 antagonist | |||
| 0.486 | 0.005 | 0.486 | c-Src kinase inhibitor | |||
| 0.477 | 0.006 | 0.599 | Alpha-N-acetylglucosaminidase inhibitor | 0.599 0.004 CID_154699678 | CID_154699678 | |
| 0.491 | 0.031 | 0.491 | Angiogenesis inhibitor | 0.254 0.12 CID_154699678 | ||
| 0.46 | 0.005 | 0.46 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.454 | 0.005 | 0.454 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.454 | 0.014 | 0.454 | Growth factor antagonist | |||
| 0.437 | 0.004 | 0.437 | Succinate dehydrogenase inhibitor | 0.203 0.046 CID_154699678 | ||
| 0.434 | 0.004 | 0.434 | GABA C receptor agonist | 0.155 0.032 CID_154699678 | ||
| 0.441 | 0.013 | 0.441 | Calcium channel activator | 0.26 0.136 CID_154699678 | ||
| 0.427 | 0.005 | 0.427 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.464 | 0.043 | 0.485 | Histamine release inhibitor | 0.485 0.034 CID_154699678 | CID_154699678 | |
| 0.423 | 0.005 | 0.423 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.415 | 0.007 | 0.415 | Lck kinase inhibitor | |||
| 0.412 | 0.008 | 0.412 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.403 | 0.014 | 0.403 | 5 Hydroxytryptamine uptake stimulant | 0.192 0.168 CID_154699678 | ||
| 0.39 | 0.008 | 0.39 | Protein kinase (CK1) gamma inhibitor | |||
| 0.389 | 0.014 | 0.389 | Vascular endothelial growth factor antagonist | |||
| 0.387 | 0.014 | 0.387 | MAP kinase kinase 2 inhibitor | |||
| 0.379 | 0.006 | 0.379 | Vascular endothelial growth factor 1 antagonist | |||
| 0.377 | 0.004 | 0.377 | Ferrochelatase inhibitor | 0.126 0.05 CID_154699678 | ||
| 0.382 | 0.01 | 0.382 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.369 | 0.008 | 0.369 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.38 | 0.02 | 0.38 | Death-associated protein kinase 3 inhibitor | |||
| 0.365 | 0.005 | 0.365 | Ephrin antagonist | |||
| 0.378 | 0.019 | 0.378 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.441 | 0.083 | 0.441 | MAP kinase 1 inhibitor | |||
| 0.352 | 0.008 | 0.761 | Platelet activating factor beta antagonist | 0.761 0.004 CID_154699678 | CID_154699678 | |
| 0.374 | 0.031 | 0.374 | Superoxide dismutase inhibitor | |||
| 0.4 | 0.058 | 0.4 | MAP kinase kinase 6 inhibitor | |||
| 0.357 | 0.015 | 0.357 | Vascular endothelial growth factor 2 antagonist | |||
| 0.341 | 0.006 | 0.341 | Epidermal growth factor antagonist | |||
| 0.346 | 0.012 | 0.346 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.365 | 0.031 | 0.365 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.338 | 0.007 | 0.338 | Interleukin 1b antagonist | |||
| 0.351 | 0.024 | 0.351 | Anesthetic general | 0.206 0.071 CID_154699678 | ||
| 0.329 | 0.005 | 0.329 | ErbB-2 antagonist | |||
| 0.327 | 0.011 | 0.327 | Aurora-A kinase inhibitor | |||
| 0.344 | 0.03 | 0.344 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.321 | 0.018 | 0.321 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.297 0.024 CID_154699678 | ||
| 0.317 | 0.022 | 0.317 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.323 | 0.03 | 0.323 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.298 | 0.011 | 0.298 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.289 | 0.005 | 0.289 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.296 | 0.012 | 0.296 | Polo-like kinase-3 inhibitor | |||
| 0.307 | 0.028 | 0.307 | Gastrin inhibitor | |||
| 0.332 | 0.052 | 0.332 | Aryl hydrocarbon receptor agonist | |||
| 0.289 | 0.014 | 0.289 | Nitric-oxide synthase stimulant | 0.184 0.12 CID_154699678 | ||
| 0.279 | 0.007 | 0.279 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.277 | 0.008 | 0.277 | GABA C receptor rho-2 antagonist | |||
| 0.273 | 0.005 | 0.273 | MAP kinase kinase 10 inhibitor | |||
| 0.37 | 0.103 | 0.37 | Calcium channel L-type activator | |||
| 0.351 | 0.086 | 0.351 | Calpain 2 inhibitor | |||
| 0.287 | 0.025 | 0.287 | RET inhibitor | |||
| 0.266 | 0.005 | 0.266 | MAP kinase kinase 5 inhibitor | |||
| 0.271 | 0.01 | 0.271 | Death-associated protein kinase 2 inhibitor | |||
| 0.265 | 0.005 | 0.265 | EphA2 antagonist | |||
| 0.31 | 0.05 | 0.31 | Transcription factor STAT inhibitor | |||
| 0.264 | 0.005 | 0.264 | MAP kinase 10 inhibitor | |||
| 0.268 | 0.012 | 0.433 | UDP-glucose 4-epimerase inhibitor | 0.433 0.004 CID_154699678 | CID_154699678 | |
| 0.289 | 0.034 | 0.289 | RNA-directed DNA polymerase inhibitor | 0.252 0.048 CID_154699678 | ||
| 0.296 | 0.043 | 0.442 | Cyclic AMP phosphodiesterase inhibitor | 0.442 0.011 CID_154699678 | CID_154699678 | |
| 0.264 | 0.013 | 0.264 | MAP kinase kinase inhibitor | |||
| 0.283 | 0.034 | 0.283 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.281 | 0.033 | 0.281 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.262 | 0.017 | 0.262 | Interleukin 1 antagonist | |||
| 0.254 | 0.011 | 0.254 | Mannose-6-phosphate isomerase inhibitor | 0.174 0.046 CID_154699678 | ||
| 0.297 | 0.054 | 0.297 | Dyrk kinase inhibitor | |||
| 0.252 | 0.01 | 0.252 | MAP kinase 8 inhibitor | |||
| 0.3 | 0.059 | 0.3 | Insulysin inhibitor | |||
| 0.276 | 0.036 | 0.276 | DNA methyltransferase I inhibitor | 0.263 0.042 CID_154699678 | ||
| 0.243 | 0.004 | 0.243 | Protein kinase C theta inhibitor | |||
| 0.255 | 0.015 | 0.255 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.243 | 0.005 | 0.243 | ErbB-3 antagonist | |||
| 0.24 | 0.005 | 0.24 | Alcohol oxidase inhibitor | 0.138 0.012 CID_154699678 | ||
| 0.316 | 0.081 | 0.425 | Cholesterol antagonist | 0.425 0.045 CID_154699678 | CID_154699678 | |
| 0.241 | 0.007 | 0.241 | GABA C receptor antagonist | |||
| 0.238 | 0.005 | 0.238 | Electrolyte absorption antagonist | |||
| 0.263 | 0.031 | 0.263 | Focal adhesion kinase 2 inhibitor | |||
| 0.254 | 0.021 | 0.254 | Glycogen synthase kinase-3 inhibitor | |||
| 0.243 | 0.01 | 0.243 | Check point kinase 2 inhibitor | |||
| 0.27 | 0.038 | 0.27 | DNA methylase inhibitor | 0.261 0.042 CID_154699678 | ||
| 0.285 | 0.056 | 0.302 | Interleukin agonist | 0.302 0.047 CID_154699678 | CID_154699678 | |
| 0.308 | 0.081 | 0.344 | Vasodilator, coronary | 0.344 0.058 CID_154699678 | CID_154699678 | |
| 0.238 | 0.012 | 0.238 | Aurora-C kinase inhibitor | |||
| 0.234 | 0.009 | 0.234 | Porphobilinogen synthase inhibitor | 0.066 0.06 CID_154699678 | ||
| 0.233 | 0.009 | 0.233 | CF transmembrane conductance regulator agonist | |||
| 0.29 | 0.067 | 0.29 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.279 | 0.056 | 0.279 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.243 | 0.021 | 0.243 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.241 | 0.019 | 0.241 | Hexokinase inhibitor | 0.194 0.039 CID_154699678 | ||
| 0.236 | 0.017 | 0.236 | ATPase inhibitor | 0.2 0.037 CID_154699678 | ||
| 0.26 | 0.043 | 0.26 | CDC-like kinase 4 inhibitor | |||
| 0.233 | 0.015 | 0.233 | CDK/cyclin complex inhibitor | |||
| 0.231 | 0.015 | 0.231 | MAP kinase 12 inhibitor | |||
| 0.222 | 0.005 | 0.222 | GABA C receptor rho-1 antagonist | |||
| 0.27 | 0.054 | 0.27 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.264 | 0.049 | 0.264 | Clk dual-specificity kinase inhibitor | |||
| 0.226 | 0.012 | 0.226 | Cyclooxygenase 3 inhibitor | 0.204 0.017 CID_154699678 | ||
| 0.296 | 0.082 | 0.296 | 12-Lipoxygenase inhibitor | |||
| 0.221 | 0.009 | 0.326 | Triose-phosphate isomerase inhibitor | 0.326 0.004 CID_154699678 | CID_154699678 | |
| 0.225 | 0.012 | 0.293 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.293 0.007 CID_154699678 | CID_154699678 | |
| 0.279 | 0.066 | 0.279 | DNA damaging | 0.248 0.081 CID_154699678 | ||
| 0.257 | 0.046 | 0.257 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.221 | 0.01 | 0.221 | 5 Hydroxytryptamine 3A agonist | |||
| 0.255 | 0.044 | 0.255 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.248 | 0.038 | 0.248 | I kappa B kinase epsilon inhibitor | |||
| 0.218 | 0.008 | 0.218 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.266 | 0.057 | 0.51 | DNA synthesis inhibitor | 0.51 0.013 CID_154699678 | CID_154699678 | |
| 0.218 | 0.009 | 0.218 | Interleukin 8 antagonist | |||
| 0.224 | 0.015 | 0.224 | MAP kinase 13 inhibitor | |||
| 0.211 | 0.003 | 0.211 | CXC chemokine 1 receptor antagonist | |||
| 0.219 | 0.013 | 0.318 | Adenylate kinase inhibitor | 0.318 0.006 CID_154699678 | CID_154699678 | |
| 0.22 | 0.015 | 0.22 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.207 | 0.004 | 0.207 | CC chemokine 6 receptor antagonist | 0.152 0.02 CID_154699678 | ||
| 0.225 | 0.022 | 0.225 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.22 | 0.017 | 0.22 | Arachidonic acid antagonist | 0.17 0.065 CID_154699678 | ||
| 0.233 | 0.031 | 0.233 | Vascular endothelial growth factor 3 antagonist | |||
| 0.232 | 0.03 | 0.232 | Cyclin-dependent kinase inhibitor | |||
| 0.21 | 0.011 | 0.21 | ErbB-4 antagonist | |||
| 0.209 | 0.013 | 0.209 | Potassium channel (Ca-activated) activator | |||
| 0.244 | 0.048 | 0.244 | CDC-like kinase 2 inhibitor | |||
| 0.2 | 0.005 | 0.2 | MAP kinase kinase 1 inhibitor | |||
| 0.23 | 0.037 | 0.23 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.227 | 0.034 | 0.227 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.206 | 0.013 | 0.206 | CDK2/cyclin A inhibitor | |||
| 0.236 | 0.045 | 0.236 | LIM domain kinase 1 inhibitor | |||
| 0.231 | 0.04 | 0.231 | Growth factor agonist | |||
| 0.25 | 0.059 | 0.25 | Antimitotic | |||
| 0.2 | 0.01 | 0.401 | NADH dehydrogenase inhibitor | 0.401 0.005 CID_154699678 | CID_154699678 | |
| 0.222 | 0.034 | 0.222 | Interferon gamma antagonist | 0.198 0.042 CID_154699678 | ||
| 0.195 | 0.009 | 0.195 | Protein kinase C delta inhibitor | |||
| 0.196 | 0.012 | 0.196 | MAP kinase 14 inhibitor | |||
| 0.196 | 0.013 | 0.196 | Raf kinase inhibitor | |||
| 0.2 | 0.018 | 0.2 | MAP kinase kinase kinase inhibitor | |||
| 0.193 | 0.012 | 0.193 | Creatine kinase inhibitor | 0.117 0.043 CID_154699678 | ||
| 0.199 | 0.019 | 0.199 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.233 | 0.052 | 0.233 | MAP kinase kinase 3 inhibitor | |||
| 0.202 | 0.022 | 0.202 | MAP kinase 3 inhibitor | |||
| 0.198 | 0.019 | 0.198 | Carbonic anhydrase XV inhibitor | |||
| 0.23 | 0.052 | 0.23 | Neurotrophic factor enhancer | 0.153 0.133 CID_154699678 | ||
| 0.199 | 0.024 | 0.199 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.201 | 0.026 | 0.558 | Platelet activating factor antagonist | 0.558 0.004 CID_154699678 | CID_154699678 | |
| 0.304 | 0.129 | 0.304 | 15-Lipoxygenase inhibitor | |||
| 0.197 | 0.023 | 0.197 | Cathepsin H inhibitor | |||
| 0.201 | 0.028 | 0.201 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.2 | 0.028 | 0.2 | Abl kinase inhibitor | |||
| 0.179 | 0.008 | 0.179 | Histamine N-methyltransferase inhibitor | |||
| 0.179 | 0.008 | 0.179 | CDK9/cyclin T1 inhibitor | |||
| 0.179 | 0.008 | 0.179 | Cyclin B3 inhibitor | |||
| 0.179 | 0.009 | 0.179 | Toll-Like receptor 3 antagonist | |||
| 0.19 | 0.02 | 0.19 | Beta amyloid protein antagonist | 0.106 0.083 CID_154699678 | ||
| 0.208 | 0.039 | 0.208 | Phospholipase C inhibitor | 0.206 0.04 CID_154699678 | ||
| 0.179 | 0.01 | 0.179 | Transcription factor STAT6 inhibitor | |||
| 0.19 | 0.024 | 0.19 | MAP kinase 9 inhibitor | |||
| 0.231 | 0.067 | 0.231 | Pyruvate kinase inhibitor | |||
| 0.239 | 0.076 | 0.239 | Calpain inhibitor | |||
| 0.209 | 0.048 | 0.209 | Tumour necrosis factor antagonist | |||
| 0.172 | 0.011 | 0.172 | Ca2+-transporting ATPase inhibitor | 0.168 0.015 CID_154699678 | ||
| 0.225 | 0.065 | 0.843 | Platelet aggregation inhibitor | 0.843 0.004 CID_154699678 | CID_154699678 | |
| 0.171 | 0.011 | 0.171 | Keratolytic | |||
| 0.218 | 0.058 | 0.218 | Non-steroidal antiinflammatory agent | |||
| 0.167 | 0.008 | 0.231 | Biliverdin reductase inhibitor | 0.231 0.004 CID_154699678 | CID_154699678 | |
| 0.236 | 0.078 | 0.236 | Antiamyloidogenic | 0.187 0.109 CID_154699678 | ||
| 0.186 | 0.028 | 0.186 | Cystathionine beta-synthase inhibitor | 0.134 0.049 CID_154699678 | ||
| 0.206 | 0.049 | 0.206 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.181 | 0.026 | 0.181 | MAP3K9 inhibitor | |||
| 0.269 | 0.114 | 0.269 | Vasodilator, peripheral | 0.238 0.137 CID_154699678 | ||
| 0.171 | 0.017 | 0.171 | Telomerase inhibitor | |||
| 0.209 | 0.057 | 0.209 | Histone acetyltransferase inhibitor | |||
| 0.178 | 0.026 | 0.178 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.179 | 0.027 | 0.179 | Adenylate cyclase stimulant | 0.158 0.05 CID_154699678 | ||
| 0.159 | 0.008 | 0.159 | Focal adhesion kinase 1 inhibitor | |||
| 0.172 | 0.021 | 0.172 | Protein kinase C gamma inhibitor | |||
| 0.158 | 0.007 | 0.158 | NMDA receptor agonist | |||
| 0.228 | 0.078 | 0.228 | Neuropeptide Y2 antagonist | |||
| 0.188 | 0.038 | 0.188 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.171 | 0.022 | 0.171 | Carbonic anhydrase III inhibitor | 0.092 0.072 CID_154699678 | ||
| 0.188 | 0.042 | 0.188 | Neurotensin receptor agonist | |||
| 0.192 | 0.047 | 0.233 | Amylase inhibitor | 0.233 0.033 CID_154699678 | CID_154699678 | |
| 0.149 | 0.004 | 0.149 | NMDA receptor glycine site agonist | |||
| 0.193 | 0.05 | 0.193 | Protein kinase C nu inhibitor | |||
| 0.161 | 0.018 | 0.161 | Histidine decarboxylase inhibitor | 0.062 0.06 CID_154699678 | ||
| 0.218 | 0.075 | 0.218 | Interleukin antagonist | |||
| 0.153 | 0.01 | 0.153 | Protein kinase C alpha inhibitor | |||
| 0.165 | 0.022 | 0.165 | Death-associated protein kinase 1 inhibitor | |||
| 0.173 | 0.031 | 0.173 | Protein kinase (CK2) alpha inhibitor | |||
| 0.164 | 0.023 | 0.164 | Heat shock protein 70 antagonist | 0.161 0.026 CID_154699678 | ||
| 0.152 | 0.012 | 0.152 | Interleukin 12 antagonist | |||
| 0.151 | 0.013 | 0.151 | CDK1/cyclin B inhibitor | |||
| 0.144 | 0.008 | 0.149 | Purinergic P2X1 antagonist | 0.149 0.007 CID_154699678 | CID_154699678 | |
| 0.184 | 0.048 | 0.184 | Protein kinase stimulant | 0.153 0.066 CID_154699678 | ||
| 0.233 | 0.098 | 0.233 | Transcription factor STAT3 inhibitor | |||
| 0.142 | 0.007 | 0.142 | CDC25B inhibitor | |||
| 0.151 | 0.017 | 0.151 | MAP kinase 11 inhibitor | |||
| 0.137 | 0.003 | 0.137 | Potassium channel Kv1.1 blocker | |||
| 0.152 | 0.019 | 0.152 | Potassium channel activator | |||
| 0.145 | 0.013 | 0.147 | Lanosterol 14 alpha demethylase inhibitor | 0.147 0.012 CID_154699678 | CID_154699678 | |
| 0.161 | 0.029 | 0.161 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.149 | 0.018 | 0.272 | Phosphofructokinase-1 inhibitor | 0.272 0.006 CID_154699678 | CID_154699678 | |
| 0.163 | 0.032 | 0.163 | Aminopeptidase B inhibitor | |||
| 0.158 | 0.027 | 0.158 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.159 | 0.029 | 0.159 | Alpha 2c adrenoreceptor antagonist | |||
| 0.144 | 0.015 | 0.144 | Raf kinase C inhibitor | |||
| 0.142 | 0.013 | 0.142 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 CID_154699678 | ||
| 0.137 | 0.008 | 0.137 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.14 | 0.013 | 0.14 | Myeloperoxidase inhibitor | |||
| 0.156 | 0.03 | 0.156 | Protein kinase (CK2) inhibitor | |||
| 0.149 | 0.023 | 0.149 | Prolactin inhibitor | |||
| 0.147 | 0.021 | 0.147 | Carbonic anhydrase VI inhibitor | |||
| 0.175 | 0.05 | 0.175 | Activin receptor-like kinase 2 inhibitor | |||
| 0.138 | 0.013 | 0.16 | Carbamoyl phosphate synthetase inhibitor | 0.16 0.01 CID_154699678 | CID_154699678 | |
| 0.178 | 0.054 | 0.178 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.147 | 0.023 | 0.147 | DOPA decarboxylase inhibitor | |||
| 0.236 | 0.113 | 0.236 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.149 | 0.027 | 0.149 | CDK3/cyclin E inhibitor | |||
| 0.148 | 0.028 | 0.148 | Gastric antisecretory | |||
| 0.126 | 0.006 | 0.126 | Protein kinase C beta inhibitor | |||
| 0.147 | 0.027 | 0.147 | Catalase inhibitor | |||
| 0.135 | 0.015 | 0.135 | CDK2/cyclin E inhibitor | |||
| 0.124 | 0.004 | 0.124 | Dihydroorotase inhibitor | |||
| 0.134 | 0.015 | 0.134 | Bromodomain-containing protein 2 inhibitor | |||
| 0.141 | 0.023 | 0.141 | Janus tyrosine kinase 2 inhibitor | |||
| 0.137 | 0.018 | 0.2 | Glutamate dehydrogenase inhibitor | 0.2 0.01 CID_154699678 | CID_154699678 | |
| 0.124 | 0.007 | 0.124 | Topoisomerase II beta inhibitor | |||
| 0.128 | 0.01 | 0.128 | D-Ala-D-Ala ligase inhibitor | |||
| 0.135 | 0.018 | 0.135 | Glutamate (mGluR7) agonist | |||
| 0.148 | 0.032 | 0.148 | Photosensitizer | 0.137 0.04 CID_154699678 | ||
| 0.168 | 0.052 | 0.168 | Toll-Like receptor 9 antagonist | |||
| 0.179 | 0.063 | 0.179 | Heat shock protein 90 alpha antagonist | |||
| 0.138 | 0.023 | 0.138 | Stem cell growth factor agonist | |||
| 0.126 | 0.012 | 0.146 | Acyl-CoA dehydrogenase inhibitor | 0.146 0.009 CID_154699678 | CID_154699678 | |
| 0.132 | 0.017 | 0.132 | Glutamate decarboxylase inhibitor | 0.071 0.054 CID_154699678 | ||
| 0.162 | 0.048 | 0.162 | NADPH oxidase inhibitor | |||
| 0.122 | 0.008 | 0.122 | Potassium channel (ATP-sensitive) blocker | |||
| 0.127 | 0.014 | 0.183 | Argininosuccinate synthase inhibitor | 0.183 0.009 CID_154699678 | CID_154699678 | |
| 0.136 | 0.023 | 0.136 | Polo-like kinase-1 inhibitor | |||
| 0.138 | 0.025 | 0.138 | Acetylcholine release stimulant | |||
| 0.116 | 0.004 | 0.116 | Dihydroorotate oxidase inhibitor | |||
| 0.136 | 0.023 | 0.136 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.132 | 0.019 | 0.132 | CDK1/cyclin B1 inhibitor | |||
| 0.166 | 0.056 | 0.166 | Thiol protease inhibitor | |||
| 0.117 | 0.007 | 0.117 | H+/K+-transporting ATPase inhibitor | |||
| 0.155 | 0.045 | 0.155 | Pregnane X receptor agonist | |||
| 0.117 | 0.008 | 0.117 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.12 | 0.011 | 0.137 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.137 0.009 CID_154699678 | CID_154699678 | |
| 0.144 | 0.036 | 0.144 | Mucolytic | 0.133 0.044 CID_154699678 | ||
| 0.129 | 0.022 | 0.129 | Protein kinase B gamma inhibitor | |||
| 0.155 | 0.049 | 0.155 | Toll-Like receptor 2 antagonist | |||
| 0.131 | 0.025 | 0.131 | ALK inhibitor | |||
| 0.123 | 0.017 | 0.123 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.124 | 0.019 | 0.124 | Glutamate release inhibitor | 0.086 0.073 CID_154699678 | ||
| 0.112 | 0.007 | 0.112 | Aconitate hydratase inhibitor | 0.059 0.027 CID_154699678 | ||
| 0.158 | 0.053 | 0.158 | Neuropeptide Y1 antagonist | |||
| 0.137 | 0.032 | 0.349 | Beta glucuronidase inhibitor | 0.349 0.005 CID_154699678 | CID_154699678 | |
| 0.115 | 0.011 | 0.115 | CDK4/cyclin D inhibitor | |||
| 0.108 | 0.004 | 0.108 | Potassium channel small-conductance Ca-activated activator | |||
| 0.115 | 0.011 | 0.115 | Alpha 2 adrenoreceptor agonist | |||
| 0.149 | 0.045 | 0.149 | Histone deacetylase class III inhibitor | |||
| 0.276 | 0.173 | 0.276 | Alpha-glucosidase inhibitor | 0.245 0.19 CID_154699678 | ||
| 0.159 | 0.056 | 0.159 | Cytokine production inhibitor | |||
| 0.127 | 0.024 | 0.127 | p38 MAP kinase inhibitor | |||
| 0.12 | 0.018 | 0.179 | Glycine receptor antagonist | 0.179 0.004 CID_154699678 | CID_154699678 | |
| 0.166 | 0.064 | 0.166 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.142 | 0.04 | 0.142 | Falcipain 3 inhibitor | |||
| 0.121 | 0.018 | 0.121 | Raf kinase B inhibitor | |||
| 0.145 | 0.043 | 0.145 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.18 | 0.079 | 0.18 | TRKC antagonist | |||
| 0.109 | 0.007 | 0.109 | MAP kinase kinase 7 inhibitor | |||
| 0.187 | 0.085 | 0.187 | Amyloid beta aggregation inhibitor | |||
| 0.118 | 0.017 | 0.118 | Histone deacetylase SIRT2 inhibitor | |||
| 0.11 | 0.009 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.077 0.043 CID_154699678 | ||
| 0.136 | 0.036 | 0.136 | Platelet activating factor alpha antagonist | |||
| 0.109 | 0.009 | 0.109 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.16 | 0.06 | 0.16 | Protein kinase (CK1) inhibitor | |||
| 0.147 | 0.048 | 0.305 | Alkylator | 0.305 0.012 CID_154699678 | CID_154699678 | |
| 0.22 | 0.121 | 0.22 | Lipoxygenase inhibitor | |||
| 0.104 | 0.007 | 0.104 | Sphingosine kinase 2 inhibitor | |||
| 0.125 | 0.029 | 0.125 | Protein kinase C zeta inhibitor | |||
| 0.121 | 0.025 | 0.121 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.137 | 0.042 | 0.137 | TRPA1 agonist | |||
| 0.234 | 0.139 | 0.303 | Transcription factor NF kappa B inhibitor | 0.303 0.093 CID_154699678 | CID_154699678 | |
| 0.116 | 0.022 | 0.116 | Tyk2 inhibitor | |||
| 0.115 | 0.021 | 0.115 | Aminopeptidase I inhibitor | |||
| 0.103 | 0.009 | 0.103 | Glutamate (mGluR7) antagonist | |||
| 0.101 | 0.008 | 0.101 | Cyclin D1 inhibitor | |||
| 0.108 | 0.015 | 0.108 | CC chemokine 5 receptor agonist | |||
| 0.111 | 0.02 | 0.111 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.095 | 0.004 | 0.095 | Alpha 1d adrenoreceptor agonist | |||
| 0.214 | 0.124 | 0.214 | Streptokinase A inhibitor | |||
| 0.107 | 0.017 | 0.107 | Estrogen-related receptor beta agonist | |||
| 0.102 | 0.013 | 0.102 | Phospholipase D inhibitor | |||
| 0.152 | 0.063 | 0.191 | Cell wall synthesis inhibitor | 0.191 0.034 CID_154699678 | CID_154699678 | |
| 0.11 | 0.021 | 0.11 | GABA aminotransferase inhibitor | 0.08 0.046 CID_154699678 | ||
| 0.117 | 0.028 | 0.117 | CYP2A6 inhibitor | |||
| 0.12 | 0.032 | 0.12 | Potassium channel (Voltage-sensitive) activator | |||
| 0.133 | 0.045 | 0.133 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.126 | 0.037 | 0.126 | Interleukin 2 antagonist | |||
| 0.124 | 0.036 | 0.124 | Anabolic | 0.112 0.047 CID_154699678 | ||
| 0.127 | 0.039 | 0.127 | Urease inhibitor | |||
| 0.126 | 0.038 | 0.126 | Insulin receptor antagonist | |||
| 0.121 | 0.033 | 0.121 | Insulin growth factor antagonist | |||
| 0.154 | 0.067 | 0.154 | CDC-like kinase 1 inhibitor | |||
| 0.155 | 0.069 | 0.155 | Insulin secretagoues | 0.149 0.076 CID_154699678 | ||
| 0.117 | 0.031 | 0.117 | Platelet growth factor antagonist | |||
| 0.098 | 0.012 | 0.098 | Cyclin B1 inhibitor | |||
| 0.099 | 0.015 | 0.099 | CDK4/cyclin D1 inhibitor | |||
| 0.115 | 0.031 | 0.146 | Carbonic anhydrase XIII inhibitor | 0.146 0.023 CID_154699678 | CID_154699678 | |
| 0.114 | 0.03 | 0.114 | Bcr-Abl kinase inhibitor | |||
| 0.202 | 0.119 | 0.482 | Immunostimulant | 0.482 0.031 CID_154699678 | CID_154699678 | |
| 0.122 | 0.039 | 0.122 | Hedgehog signaling inhibitor | |||
| 0.13 | 0.047 | 0.13 | Caspase 3 inhibitor | |||
| 0.12 | 0.037 | 0.12 | DNA directed RNA polymerase inhibitor | |||
| 0.103 | 0.02 | 0.103 | MAP3K7 inhibitor | |||
| 0.111 | 0.029 | 0.111 | Janus tyrosine kinase 3 inhibitor | |||
| 0.137 | 0.055 | 0.137 | Vanilloid 1 agonist | |||
| 0.087 | 0.005 | 0.087 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.117 | 0.035 | 0.117 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.125 | 0.043 | 0.125 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.118 | 0.037 | 0.118 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.098 | 0.018 | 0.098 | GABA B receptor agonist | |||
| 0.092 | 0.011 | 0.092 | Cyclin H inhibitor | |||
| 0.154 | 0.074 | 0.218 | Diuretic | 0.218 0.038 CID_154699678 | CID_154699678 | |
| 0.092 | 0.011 | 0.092 | Glutamate (mGluR group III) agonist | |||
| 0.113 | 0.033 | 0.113 | Insulin like growth factor 1 antagonist | |||
| 0.153 | 0.073 | 0.153 | Cytidine deaminase inhibitor | 0.119 0.102 CID_154699678 | ||
| 0.084 | 0.005 | 0.084 | Sirtuin 2 inhibitor | |||
| 0.092 | 0.014 | 0.092 | Glutamate (mGluR6) antagonist | 0.072 0.036 CID_154699678 | ||
| 0.117 | 0.039 | 0.117 | Nitric-oxide synthase inhibitor | |||
| 0.133 | 0.055 | 0.133 | Aurora-B kinase inhibitor | |||
| 0.089 | 0.011 | 0.089 | Cyclin B2 inhibitor | |||
| 0.135 | 0.057 | 0.135 | Aldehyde dehydrogenase inhibitor | 0.131 0.061 CID_154699678 | ||
| 0.083 | 0.006 | 0.083 | Dihydropteroate synthase inhibitor | |||
| 0.096 | 0.02 | 0.096 | Vanilloid 4 agonist | |||
| 0.099 | 0.022 | 0.099 | MAP kinase kinase 8 inhibitor | |||
| 0.141 | 0.065 | 0.141 | Nav1.6 sodium channel blocker | |||
| 0.225 | 0.149 | 0.37 | Antithrombotic | 0.37 0.058 CID_154699678 | CID_154699678 | |
| 0.108 | 0.033 | 0.108 | MAP-kinase-activated kinase inhibitor | |||
| 0.09 | 0.015 | 0.09 | Exportin-1 inhibitor | |||
| 0.108 | 0.034 | 0.108 | AXL receptor tyrosine kinase inhibitor | |||
| 0.127 | 0.053 | 0.16 | Microtubule formation inhibitor | 0.16 0.033 CID_154699678 | CID_154699678 | |
| 0.138 | 0.064 | 0.138 | Cyclooxygenase 1 inhibitor | |||
| 0.078 | 0.004 | 0.078 | Protein kinase C beta II inhibitor | |||
| 0.097 | 0.023 | 0.097 | Glycine receptor agonist | 0.093 0.025 CID_154699678 | ||
| 0.108 | 0.034 | 0.108 | Bile acid receptor antagonist | |||
| 0.096 | 0.023 | 0.096 | Transforming growth factor antagonist | |||
| 0.08 | 0.008 | 0.08 | Potassium channel (Inward rectifier) activator | |||
| 0.131 | 0.059 | 0.131 | Adenylate cyclase inhibitor | 0.116 0.071 CID_154699678 | ||
| 0.088 | 0.016 | 0.088 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.078 | 0.006 | 0.078 | Dopamine D5 agonist | |||
| 0.085 | 0.014 | 0.085 | Cyclin B inhibitor | |||
| 0.08 | 0.009 | 0.096 | Glucose-6-phosphate isomerase inhibitor | 0.096 0.005 CID_154699678 | CID_154699678 | |
| 0.098 | 0.027 | 0.098 | Vanilloid 1 antagonist | |||
| 0.128 | 0.057 | 0.15 | DNA repair enzyme inhibitor | 0.15 0.032 CID_154699678 | CID_154699678 | |
| 0.122 | 0.052 | 0.122 | Nav1.5 sodium channel blocker | |||
| 0.121 | 0.051 | 0.121 | Activin receptor-like kinase 4 inhibitor | |||
| 0.084 | 0.014 | 0.084 | Sphingosine kinase inhibitor | |||
| 0.082 | 0.012 | 0.082 | Potassium channel (Inward rectifier) blocker | |||
| 0.073 | 0.003 | 0.073 | Alpha 2a adrenoreceptor agonist | |||
| 0.077 | 0.008 | 0.077 | Potassium channel (ATP-sensitive) activator | |||
| 0.098 | 0.029 | 0.098 | CDC25A inhibitor | |||
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | |||
| 0.116 | 0.048 | 0.116 | CDC-like kinase 3 inhibitor | |||
| 0.095 | 0.027 | 0.095 | Carbonic anhydrase VA inhibitor | |||
| 0.088 | 0.02 | 0.088 | Potassium channel (Tandem pore domain) blocker | |||
| 0.082 | 0.014 | 0.119 | Glucosylceramidase inhibitor | 0.119 0.005 CID_154699678 | CID_154699678 | |
| 0.089 | 0.021 | 0.089 | 5 Hydroxytryptamine 3 agonist | |||
| 0.102 | 0.035 | 0.102 | Adrenaline agonist | |||
| 0.076 | 0.009 | 0.076 | CDK7/cyclin H inhibitor | |||
| 0.07 | 0.003 | 0.07 | MAP3K8 inhibitor | |||
| 0.113 | 0.047 | 0.113 | Sphingomyelinase inhibitor | |||
| 0.149 | 0.083 | 0.15 | Melanin inhibitor | 0.15 0.082 CID_154699678 | CID_154699678 | |
| 0.097 | 0.031 | 0.097 | Caspase 7 inhibitor | |||
| 0.108 | 0.042 | 0.108 | Calcium antagonist | |||
| 0.074 | 0.01 | 0.074 | Thymidine kinase inhibitor | 0.042 0.027 CID_154699678 | ||
| 0.167 | 0.102 | 0.167 | Psychostimulant | |||
| 0.074 | 0.01 | 0.074 | Adenylate cyclase 1 inhibitor | |||
| 0.144 | 0.08 | 0.144 | Heat shock protein 90 antagonist | |||
| 0.089 | 0.026 | 0.089 | Janus tyrosine kinase 1 inhibitor | |||
| 0.093 | 0.03 | 0.093 | Carbonic anhydrase V inhibitor | |||
| 0.099 | 0.036 | 0.099 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.09 | 0.028 | 0.09 | Fibroblast growth factor 2 antagonist | |||
| 0.074 | 0.012 | 0.074 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.107 | 0.046 | 0.107 | Alcohol dehydrogenase inhibitor | |||
| 0.097 | 0.036 | 0.097 | mTOR complex 2 inhibitor | |||
| 0.082 | 0.022 | 0.082 | Carbonic anhydrase VB inhibitor | |||
| 0.104 | 0.044 | 0.104 | Phosphodiesterase 6D inhibitor | |||
| 0.087 | 0.028 | 0.087 | Secretase beta inhibitor | |||
| 0.078 | 0.019 | 0.078 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.1 | 0.041 | 0.1 | TIE antagonist | |||
| 0.062 | 0.005 | 0.062 | Protein kinase (CK2) beta inhibitor | |||
| 0.08 | 0.023 | 0.08 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.075 | 0.018 | 0.075 | MAP kinase kinase 9 inhibitor | |||
| 0.063 | 0.006 | 0.063 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.113 | 0.056 | 0.211 | Expectorant | 0.211 0.018 CID_154699678 | CID_154699678 | |
| 0.07 | 0.014 | 0.07 | Cathepsin L2 inhibitor | |||
| 0.078 | 0.022 | 0.078 | MDM2 inhibitor | |||
| 0.063 | 0.007 | 0.063 | Purinergic P2Y2 antagonist | |||
| 0.078 | 0.022 | 0.09 | Ornithine carbamoyltransferase inhibitor | 0.09 0.018 CID_154699678 | CID_154699678 | |
| 0.102 | 0.046 | 0.102 | Alpha 2 adrenoreceptor antagonist | |||
| 0.06 | 0.005 | 0.06 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.248 | 0.193 | 0.248 | DNA directed DNA polymerase inhibitor | |||
| 0.088 | 0.033 | 0.088 | Alpha adrenoreceptor agonist | |||
| 0.093 | 0.038 | 0.093 | Phosphodiesterase 3A inhibitor | |||
| 0.1 | 0.045 | 0.1 | Pim-3 kinase inhibitor | |||
| 0.081 | 0.027 | 0.081 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.073 | 0.019 | 0.073 | Cyclin A1 inhibitor | |||
| 0.076 | 0.022 | 0.076 | Transcription factor RelA inhibitor | |||
| 0.166 | 0.112 | 0.166 | Insulin sensitizer | |||
| 0.07 | 0.017 | 0.209 | Alpha-mannosidase inhibitor | 0.209 0.003 CID_154699678 | CID_154699678 | |
| 0.061 | 0.008 | 0.061 | Histamine H1 receptor agonist | |||
| 0.065 | 0.012 | 0.065 | Histamine H2 receptor agonist | |||
| 0.091 | 0.039 | 0.091 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.07 | 0.017 | 0.07 | Ryanodine receptor antagonist | |||
| 0.057 | 0.005 | 0.057 | CXC chemokine 2 receptor antagonist | |||
| 0.085 | 0.033 | 0.085 | Phosphodiesterase 4B inhibitor | |||
| 0.059 | 0.007 | 0.059 | Glutamate (mGluR8) agonist | 0.036 0.031 CID_154699678 | ||
| 0.064 | 0.013 | 0.064 | CC chemokine 4 receptor antagonist | |||
| 0.091 | 0.04 | 0.091 | Vanilloid antagonist | |||
| 0.063 | 0.012 | 0.063 | Dopamine beta hydroxylase inhibitor | |||
| 0.146 | 0.095 | 0.146 | Interleukin 6 antagonist | |||
| 0.119 | 0.068 | 0.119 | TRKA antagonist | |||
| 0.082 | 0.032 | 0.082 | Acetylcholine M5 receptor agonist | |||
| 0.15 | 0.101 | 0.15 | Amyloid beta precursor protein antagonist | |||
| 0.113 | 0.064 | 0.113 | Alpha 2b adrenoreceptor antagonist | |||
| 0.118 | 0.069 | 0.118 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.06 | 0.012 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 CID_154699678 | CID_154699678 | |
| 0.082 | 0.034 | 0.082 | CDC7 inhibitor | |||
| 0.086 | 0.038 | 0.086 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.073 | 0.025 | 0.073 | Histone deacetylase SIRT3 inhibitor | |||
| 0.074 | 0.026 | 0.074 | EphB4 antagonist | |||
| 0.056 | 0.009 | 0.056 | Glutamate (mGluR4) agonist | |||
| 0.088 | 0.041 | 0.088 | Transforming growth factor beta 3 antagonist | |||
| 0.062 | 0.016 | 0.062 | Cyclin D3 inhibitor | |||
| 0.071 | 0.025 | 0.071 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.061 | 0.015 | 0.061 | CDK5/p25 inhibitor | |||
| 0.068 | 0.022 | 0.068 | Beta 2 adrenoreceptor agonist | |||
| 0.057 | 0.011 | 0.057 | Sphingosine kinase 1 inhibitor | |||
| 0.061 | 0.016 | 0.226 | Mannosidase inhibitor | 0.226 0.003 CID_154699678 | CID_154699678 | |
| 0.071 | 0.026 | 0.071 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.055 | 0.01 | 0.055 | Kainate receptor agonist | 0.041 0.028 CID_154699678 | ||
| 0.134 | 0.089 | 0.135 | Hemostatic | 0.135 0.088 CID_154699678 | CID_154699678 | |
| 0.088 | 0.043 | 0.088 | Na+ K+ transporting ATPase inhibitor | 0.086 0.045 CID_154699678 | ||
| 0.091 | 0.046 | 0.091 | TIE-2 antagonist | |||
| 0.076 | 0.031 | 0.076 | Aryl hydrocarbon receptor antagonist | |||
| 0.068 | 0.023 | 0.068 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.056 | 0.011 | 0.056 | Diamine oxidase inhibitor | |||
| 0.063 | 0.018 | 0.063 | Purinergic P2Y antagonist | 0.041 0.035 CID_154699678 | ||
| 0.065 | 0.021 | 0.065 | Pregnane X receptor antagonist | |||
| 0.077 | 0.034 | 0.077 | Cyclin A2 inhibitor | |||
| 0.083 | 0.04 | 0.083 | Adenosine A3 receptor antagonist | 0.071 0.057 CID_154699678 | ||
| 0.1 | 0.057 | 0.1 | Protein kinase C mu inhibitor | |||
| 0.072 | 0.03 | 0.072 | Carbonic anhydrase stimulant | |||
| 0.062 | 0.021 | 0.062 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.064 | 0.023 | 0.064 | Epithelial sodium channel blocker | |||
| 0.045 | 0.004 | 0.045 | Imidazoline I1 receptor antagonist | |||
| 0.089 | 0.049 | 0.089 | Inducible nitric-oxide synthase inhibitor | |||
| 0.053 | 0.013 | 0.053 | Vascular adhesion protein 1 inhibitor | |||
| 0.052 | 0.013 | 0.095 | Fumarate hydratase inhibitor | 0.095 0.006 CID_154699678 | CID_154699678 | |
| 0.063 | 0.023 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.063 | 0.024 | 0.063 | Transforming growth factor beta 1 antagonist | |||
| 0.074 | 0.035 | 0.074 | Cyclin A inhibitor | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.079 | 0.04 | 0.079 | Prostaglandin-E synthase inhibitor | |||
| 0.078 | 0.04 | 0.078 | CDK2/cyclin E2 inhibitor | |||
| 0.091 | 0.052 | 0.091 | Phosphodiesterase IV inhibitor | |||
| 0.066 | 0.028 | 0.066 | Bruton tyrosine kinase inhibitor | |||
| 0.122 | 0.084 | 0.122 | Tyrosine-protein kinase receptor antagonist | |||
| 0.121 | 0.084 | 0.121 | Interleukin 4 antagonist | |||
| 0.058 | 0.021 | 0.058 | Aldosterone antagonist | |||
| 0.042 | 0.005 | 0.042 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.017 CID_154699678 | ||
| 0.062 | 0.025 | 0.062 | Leukotriene C antagonist | |||
| 0.045 | 0.008 | 0.045 | CDK4/cyclin D3 inhibitor | |||
| 0.041 | 0.005 | 0.041 | DNA polymerase III inhibitor | |||
| 0.068 | 0.032 | 0.068 | Calcium channel P-type blocker | |||
| 0.085 | 0.05 | 0.085 | Acetylcholine nicotinic agonist | |||
| 0.039 | 0.003 | 0.039 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.096 | 0.061 | 0.096 | Pim-1 kinase inhibitor | |||
| 0.054 | 0.019 | 0.054 | Purinergic P2X4 antagonist | |||
| 0.047 | 0.012 | 0.047 | Purinergic P2X3 antagonist | |||
| 0.065 | 0.031 | 0.065 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.068 | 0.034 | 0.068 | TRPA1 antagonist | |||
| 0.109 | 0.075 | 0.109 | Anesthetic local | |||
| 0.08 | 0.046 | 0.08 | Rho-associated kinase I inhibitor | |||
| 0.049 | 0.015 | 0.049 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.039 | 0.004 | 0.039 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.06 | 0.026 | 0.06 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.082 | 0.048 | 0.082 | Interferon agonist | |||
| 0.102 | 0.068 | 0.159 | AMP-activated protein kinase stimulant | 0.159 0.023 CID_154699678 | CID_154699678 | |
| 0.095 | 0.062 | 0.095 | Phosphodiesterase 7B inhibitor | |||
| 0.069 | 0.036 | 0.069 | Interferon inducer | |||
| 0.062 | 0.029 | 0.062 | Protein kinase C epsilon inhibitor | |||
| 0.086 | 0.053 | 0.086 | Glutathione S-transferase inhibitor | |||
| 0.054 | 0.021 | 0.054 | Cytokine production stimulant | |||
| 0.094 | 0.062 | 0.094 | Fibroblast growth factor 1 antagonist | |||
| 0.041 | 0.009 | 0.041 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.058 | 0.026 | 0.058 | Beta 2 adrenoreceptor antagonist | |||
| 0.04 | 0.008 | 0.04 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.039 | 0.007 | 0.039 | Purinergic P2Y15 antagonist | 0.035 0.01 CID_154699678 | ||
| 0.051 | 0.02 | 0.051 | Glutamate (mGluR4) antagonist | |||
| 0.042 | 0.011 | 0.042 | Uridine phosphorylase inhibitor | 0.039 0.012 CID_154699678 | ||
| 0.085 | 0.055 | 0.085 | Histamine H2 receptor antagonist | |||
| 0.053 | 0.023 | 0.053 | Carbonic anhydrase IV inhibitor | |||
| 0.059 | 0.029 | 0.059 | Lysine-specific demethylase 1A inhibitor | |||
| 0.047 | 0.018 | 0.047 | Delayed rectifier potassium channel activator | |||
| 0.047 | 0.018 | 0.047 | Potassium channel KCNQ activator | |||
| 0.047 | 0.018 | 0.047 | Heme oxygenase inhibitor | |||
| 0.032 | 0.003 | 0.032 | Imidazoline I2 receptor antagonist | |||
| 0.041 | 0.012 | 0.041 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.028 0.019 CID_154699678 | ||
| 0.051 | 0.022 | 0.051 | AICAR transformylase inhibitor | 0.045 0.029 CID_154699678 | ||
| 0.04 | 0.012 | 0.04 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.085 | 0.056 | 0.085 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.084 | 0.055 | 0.084 | I kappa B kinase inhibitor | |||
| 0.055 | 0.026 | 0.066 | Adenosine deaminase inhibitor | 0.066 0.016 CID_154699678 | CID_154699678 | |
| 0.05 | 0.021 | 0.05 | Glutamate (mGluR1a) antagonist | |||
| 0.069 | 0.041 | 0.069 | Histone deacetylase inhibitor | |||
| 0.035 | 0.007 | 0.035 | Glutamate (mGluR1a) agonist | |||
| 0.049 | 0.02 | 0.049 | Nerve growth factor antagonist | |||
| 0.066 | 0.038 | 0.066 | I kappa B kinase 2 inhibitor | |||
| 0.069 | 0.04 | 0.069 | Beta adrenoreceptor antagonist | |||
| 0.041 | 0.013 | 0.041 | CDK6/cyclin D3 inhibitor | |||
| 0.047 | 0.019 | 0.047 | Membrane dipeptidase inhibitor | |||
| 0.039 | 0.011 | 0.039 | Epoxide hydrolase 1 inhibitor | |||
| 0.052 | 0.025 | 0.052 | Thymidylate synthase inhibitor | |||
| 0.063 | 0.036 | 0.105 | Carbonic anhydrase IX inhibitor | 0.105 0.019 CID_154699678 | CID_154699678 | |
| 0.119 | 0.092 | 0.119 | Ribosomal protein S6 kinase inhibitor | |||
| 0.075 | 0.048 | 0.075 | Epoxide hydrolase inhibitor | |||
| 0.087 | 0.06 | 0.087 | Ornithine decarboxylase inhibitor | |||
| 0.071 | 0.044 | 0.071 | Check point kinase 1 inhibitor | |||
| 0.116 | 0.09 | 0.116 | Toll-Like receptor antagonist | |||
| 0.078 | 0.052 | 0.078 | MAP kinase 7 inhibitor | |||
| 0.034 | 0.008 | 0.034 | Hedgehog signaling activator | |||
| 0.106 | 0.08 | 0.106 | Proteasome inhibitor | |||
| 0.073 | 0.047 | 0.073 | Syk tyrosine kinase inhibitor | |||
| 0.032 | 0.006 | 0.032 | Complement factor 1s inhibitor | |||
| 0.065 | 0.039 | 0.065 | NMDA 2C receptor antagonist | |||
| 0.115 | 0.09 | 0.115 | Sodium channel (voltage-gated) blocker | |||
| 0.034 | 0.009 | 0.034 | Nicotinic acid receptor 2 antagonist | |||
| 0.072 | 0.047 | 0.072 | CXC chemokine receptor antagonist | |||
| 0.075 | 0.05 | 0.075 | Rho-associated kinase II inhibitor | |||
| 0.054 | 0.029 | 0.158 | Carbonic anhydrase XIV inhibitor | 0.158 0.005 CID_154699678 | CID_154699678 | |
| 0.116 | 0.091 | 0.116 | Alkaline phosphatase inhibitor | |||
| 0.078 | 0.053 | 0.078 | Fibroblast growth factor 3 antagonist | |||
| 0.034 | 0.009 | 0.034 | Estrogen-related receptor gamma antagonist | |||
| 0.03 | 0.005 | 0.03 | Cyclin T1 inhibitor | |||
| 0.033 | 0.008 | 0.033 | Complement factor 1r inhibitor | |||
| 0.053 | 0.029 | 0.053 | Squalene epoxidase inhibitor | |||
| 0.043 | 0.019 | 0.043 | DNA gyrase subunit B inhibitor | |||
| 0.029 | 0.005 | 0.029 | Alpha 2c adrenoreceptor agonist | |||
| 0.029 | 0.005 | 0.029 | Alpha 2b adrenoreceptor agonist | |||
| 0.055 | 0.031 | 0.121 | Heparanase inhibitor | 0.121 0.003 CID_154699678 | CID_154699678 | |
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.044 | 0.021 | 0.044 | GABA uptake inhibitor | |||
| 0.061 | 0.038 | 0.061 | Phosphodiesterase 1A inhibitor | |||
| 0.062 | 0.038 | 0.062 | Androgen agonist | |||
| 0.087 | 0.063 | 0.087 | Phosphodiesterase I inhibitor | |||
| 0.047 | 0.023 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.09 | 0.066 | 0.09 | Breast cancer-resistant protein inhibitor | |||
| 0.114 | 0.091 | 0.114 | Nav1.2 sodium channel blocker | |||
| 0.032 | 0.009 | 0.032 | Glucosylceramidase stimulant | |||
| 0.031 | 0.008 | 0.031 | Acid ceramidase inhibitor | |||
| 0.041 | 0.019 | 0.041 | Integrin alpha2 antagonist | |||
| 0.065 | 0.043 | 0.065 | Beta 3 adrenoreceptor antagonist | |||
| 0.058 | 0.037 | 0.085 | Carbonic anhydrase II inhibitor | 0.085 0.023 CID_154699678 | CID_154699678 | |
| 0.095 | 0.074 | 0.095 | Folate antagonist | |||
| 0.036 | 0.014 | 0.036 | Cyclin E2 inhibitor | |||
| 0.042 | 0.021 | 0.042 | 5 Hydroxytryptamine 2B agonist | |||
| 0.045 | 0.024 | 0.045 | Liver X receptor alpha agonist | |||
| 0.04 | 0.019 | 0.051 | Phosphoglycerate kinase inhibitor | 0.051 0.014 CID_154699678 | CID_154699678 | |
| 0.056 | 0.035 | 0.056 | Toll-Like receptor 8 antagonist | |||
| 0.046 | 0.026 | 0.046 | Glutamate (mGluR group III) antagonist | |||
| 0.066 | 0.047 | 0.066 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.036 | 0.016 | 0.036 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.063 | 0.044 | 0.107 | Carbonic anhydrase inhibitor | 0.107 0.025 CID_154699678 | CID_154699678 | |
| 0.079 | 0.059 | 0.079 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.021 | 0.002 | 0.021 | DNA topoisomerase III inhibitor | |||
| 0.028 | 0.009 | 0.028 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.057 | 0.037 | 0.057 | 5 Hydroxytryptamine 7 agonist | |||
| 0.056 | 0.038 | 0.085 | Carbonic anhydrase I inhibitor | 0.085 0.023 CID_154699678 | CID_154699678 | |
| 0.046 | 0.028 | 0.046 | Beta adrenoreceptor agonist | |||
| 0.108 | 0.09 | 0.108 | M17 leucyl aminopeptidase inhibitor | |||
| 0.126 | 0.108 | 0.126 | Phospholipase A2 inhibitor | |||
| 0.058 | 0.04 | 0.058 | Botulinum neurotoxin type A inhibitor | |||
| 0.021 | 0.004 | 0.021 | Cyclin D2 inhibitor | |||
| 0.025 | 0.008 | 0.025 | Factor XIII inhibitor | |||
| 0.034 | 0.017 | 0.034 | Glutamate (mGluR3) agonist | |||
| 0.023 | 0.006 | 0.023 | Nicotinic acid receptor 1 antagonist | |||
| 0.021 | 0.005 | 0.021 | CDK2/cyclin A3 inhibitor | |||
| 0.039 | 0.022 | 0.039 | Nicotinic acid receptor agonist | |||
| 0.054 | 0.038 | 0.054 | Cannabinoid CB2 receptor agonist | |||
| 0.048 | 0.031 | 0.255 | Phosphorylase inhibitor | 0.255 0.004 CID_154699678 | CID_154699678 | |
| 0.039 | 0.023 | 0.039 | Vanilloid 3 antagonist | |||
| 0.047 | 0.03 | 0.047 | Oleamide hydrolase inhibitor | |||
| 0.029 | 0.013 | 0.029 | Integrin alpha2beta1 antagonist | |||
| 0.084 | 0.068 | 0.084 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.022 | 0.007 | 0.022 | Carbonic anhydrase VIII inhibitor | |||
| 0.022 | 0.007 | 0.022 | Carbonic anhydrase X inhibitor | |||
| 0.06 | 0.045 | 0.06 | Cannabinoid CB1 receptor antagonist | |||
| 0.025 | 0.01 | 0.025 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.029 | 0.013 | 0.029 | NMDA receptor glycine site antagonist | |||
| 0.028 | 0.013 | 0.028 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.031 | 0.016 | 0.031 | 5 Hydroxytryptamine 6 agonist | |||
| 0.054 | 0.039 | 0.054 | Pim-2 kinase inhibitor | |||
| 0.028 | 0.013 | 0.028 | Vanilloid 2 agonist | 0.027 0.014 CID_154699678 | ||
| 0.02 | 0.005 | 0.02 | Thromboxane A2 agonist | |||
| 0.061 | 0.047 | 0.061 | Phosphodiesterase 1C inhibitor | |||
| 0.042 | 0.028 | 0.042 | Histone deacetylase 8 inhibitor | |||
| 0.071 | 0.057 | 0.071 | Alpha 2a adrenoreceptor antagonist | |||
| 0.028 | 0.014 | 0.028 | Thymidine phosphorylase inhibitor | |||
| 0.047 | 0.034 | 0.047 | Cholesterol esterase inhibitor | |||
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.058 | 0.044 | 0.058 | Heat shock protein 90 beta antagonist | |||
| 0.017 | 0.004 | 0.017 | DNA polymerase III polC-type inhibitor | |||
| 0.051 | 0.038 | 0.127 | Carbonic anhydrase XII inhibitor | 0.127 0.015 CID_154699678 | CID_154699678 | |
| 0.043 | 0.03 | 0.043 | GABA B receptor antagonist | |||
| 0.02 | 0.007 | 0.02 | Nicotinic alpha4 receptor agonist | |||
| 0.042 | 0.029 | 0.042 | Oxytocin agonist | |||
| 0.1 | 0.087 | 0.101 | Cholesterol synthesis inhibitor | 0.101 0.086 CID_154699678 | CID_154699678 | |
| 0.12 | 0.108 | 0.12 | Acetylcholine M1 receptor antagonist | |||
| 0.073 | 0.061 | 0.073 | Macrophage migration inhibitory factor inhibitor | |||
| 0.076 | 0.064 | 0.076 | Neuropeptide Y antagonist | |||
| 0.039 | 0.027 | 0.039 | Leukotriene C4 antagonist | |||
| 0.017 | 0.005 | 0.017 | Carbonic anhydrase XI inhibitor | |||
| 0.037 | 0.026 | 0.037 | Histone deacetylase 7 inhibitor | |||
| 0.031 | 0.02 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.022 | 0.011 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.034 | 0.023 | 0.034 | Melatonin receptor 1A agonist | |||
| 0.02 | 0.009 | 0.021 | Methylmalonyl-CoA mutase inhibitor | 0.021 0.007 CID_154699678 | CID_154699678 | |
| 0.039 | 0.028 | 0.039 | MAP3K5 inhibitor | |||
| 0.02 | 0.009 | 0.02 | Complement factor D inhibitor | |||
| 0.02 | 0.009 | 0.064 | Ileal bile acid transport inhibitor | 0.064 0.003 CID_154699678 | CID_154699678 | |
| 0.028 | 0.018 | 0.028 | Lysine carboxypeptidase inhibitor | |||
| 0.087 | 0.077 | 0.087 | Xanthine oxidase inhibitor | |||
| 0.054 | 0.043 | 0.054 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.038 | 0.028 | 0.038 | Histone deacetylase 9 inhibitor | |||
| 0.031 | 0.021 | 0.031 | Elastase 3A inhibitor | |||
| 0.031 | 0.021 | 0.031 | Elastase 3B inhibitor | |||
| 0.031 | 0.021 | 0.031 | Elastase 2B inhibitor | |||
| 0.063 | 0.053 | 0.063 | Nav1.7 sodium channel blocker | |||
| 0.055 | 0.045 | 0.055 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.055 0.045 CID_154699678 | ||
| 0.023 | 0.014 | 0.037 | Adenosine kinase inhibitor | 0.037 0.008 CID_154699678 | CID_154699678 | |
| 0.05 | 0.04 | 0.05 | Histamine agonist | |||
| 0.039 | 0.029 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.059 | 0.049 | 0.059 | Cannabinoid receptor agonist | |||
| 0.037 | 0.027 | 0.037 | Delayed rectifier potassium channel blocker | |||
| 0.014 | 0.005 | 0.014 | Thrombopoietin agonist | |||
| 0.048 | 0.039 | 0.048 | CD45 antagonist | |||
| 0.017 | 0.008 | 0.017 | Purinergic P2Y1 agonist | 0.015 0.012 CID_154699678 | ||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 CID_154699678 | ||
| 0.053 | 0.045 | 0.053 | Adenosine A1 receptor antagonist | 0.052 0.047 CID_154699678 | ||
| 0.035 | 0.028 | 0.035 | Glutamate (mGluR3) antagonist | |||
| 0.114 | 0.107 | 0.114 | Cyclooxygenase inhibitor | |||
| 0.076 | 0.07 | 0.076 | Androgen antagonist | |||
| 0.018 | 0.011 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_154699678 | CID_154699678 | |
| 0.046 | 0.039 | 0.046 | Histamine H4 receptor antagonist | |||
| 0.014 | 0.008 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.045 | 0.039 | 0.045 | Benzodiazepine antagonist | |||
| 0.009 | 0.003 | 0.009 | CC chemokine 6 receptor agonist | |||
| 0.015 | 0.01 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.056 | 0.051 | 0.056 | 5 Hydroxytryptamine 2A agonist | |||
| 0.036 | 0.031 | 0.036 | Histone deacetylase class I inhibitor | |||
| 0.056 | 0.051 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.031 | 0.026 | 0.031 | Liver X receptor beta agonist | |||
| 0.05 | 0.045 | 0.05 | Nicotinic neuronal receptor agonist | |||
| 0.033 | 0.029 | 0.033 | Adenosine uptake inhibitor | |||
| 0.018 | 0.014 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.004 CID_154699678 | CID_154699678 | |
| 0.032 | 0.028 | 0.032 | Kainate receptor 2 antagonist | |||
| 0.052 | 0.048 | 0.052 | Cathepsin L inhibitor | |||
| 0.012 | 0.008 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.107 | 0.104 | 0.107 | Antibacterial (Helicobacter pylori) | |||
| 0.071 | 0.068 | 0.071 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.035 | 0.032 | 0.035 | Retinoid X receptor antagonist | |||
| 0.016 | 0.012 | 0.021 | Adenosine A2 receptor agonist | 0.021 0.007 CID_154699678 | CID_154699678 | |
| 0.032 | 0.029 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.037 | 0.033 | 0.037 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.216 | 0.213 | 0.216 | Transcription factor inhibitor | |||
| 0.03 | 0.028 | 0.03 | Vanilloid 4 antagonist | |||
| 0.048 | 0.046 | 0.048 | Nicotinic alpha7 receptor agonist | |||
| 0.036 | 0.034 | 0.036 | AMPA 4 receptor antagonist | |||
| 0.018 | 0.015 | 0.018 | Estrogen-related receptor gamma agonist | |||
| 0.021 | 0.019 | 0.021 | Beta 1 adrenoreceptor agonist | |||
| 0.052 | 0.049 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.054 | 0.052 | 0.054 | Phosphodiesterase 1B inhibitor | |||
| 0.02 | 0.018 | 0.02 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.009 | 0.007 | 0.009 | Progesterone receptor A antagonist | |||
| 0.067 | 0.065 | 0.067 | Orexin receptor 1 antagonist | |||
| 0.041 | 0.04 | 0.041 | Potassium channel Kv1.3 blocker | |||
| 0.021 | 0.02 | 0.024 | Isoleucine-tRNA ligase inhibitor | 0.024 0.012 CID_154699678 | CID_154699678 | |
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.101 | 0.1 | 0.101 | TRKB antagonist | |||
| 0.023 | 0.022 | 0.024 | Purinergic P2X agonist | 0.024 0.021 CID_154699678 | CID_154699678 | |
| 0.009 | 0.009 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.006 CID_154699678 | CID_154699678 | |
| 0.03 | 0.031 | 0.042 | Arginase inhibitor | 0.042 0.02 CID_154699678 | CID_154699678 | |
| 0.152 | 0.162 | 0.209 | Spasmolytic | 0.209 0.112 CID_154699678 | CID_154699678 | |
| 0.089 | 0.099 | 0.19 | DNA polymerase I inhibitor | 0.19 0.031 CID_154699678 | CID_154699678 | |
| 0.042 | 0.054 | 0.123 | Factor IXa inhibitor | 0.123 0.005 CID_154699678 | CID_154699678 | |
| 0.02 | 0.036 | 0.073 | Sodium/glucose cotransporter 2 inhibitor | 0.073 0.004 CID_154699678 | CID_154699678 | |
| 0.021 | 0.037 | 0.072 | Sodium/glucose cotransporter inhibitor | 0.072 0.004 CID_154699678 | CID_154699678 | |
| 0.206 | 0.222 | 0.55 | Antibacterial | 0.55 0.029 CID_154699678 | CID_154699678 | |
| 0.074 | 0.095 | 0.09 | Monophenol monooxygenase inhibitor | 0.09 0.083 CID_154699678 | CID_154699678 | |
| 0.033 | 0.053 | 0.085 | Antimetabolite | 0.085 0.019 CID_154699678 | CID_154699678 | |
| 0.008 | 0.054 | 0.014 | Adenosine A2b receptor agonist | 0.014 0.011 CID_154699678 | CID_154699678 | |
| 0.067 | 0.113 | 0.098 | Transcription factor NF kappa B stimulant | 0.098 0.041 CID_154699678 | CID_154699678 | |
| 0.015 | 0.062 | 0.028 | Prostaglandin agonist | 0.028 0.025 CID_154699678 | CID_154699678 | |
| 0.179 | 0.23 | 0.372 | Interleukin 2 agonist | 0.372 0.037 CID_154699678 | CID_154699678 | |
| 0.118 | 0.17 | 0.19 | Lipocortins synthesis antagonist | 0.19 0.063 CID_154699678 | CID_154699678 | |
| 0.009 | 0.077 | 0.029 | Adenosine A1 receptor agonist | 0.029 0.012 CID_154699678 | CID_154699678 | |
| 0.219 | 0.306 | 0.412 | Antiinflammatory | 0.412 0.133 CID_154699678 | CID_154699678 | |
| 0.002 | 0.1 | 0.013 | Purinergic receptor agonist | 0.013 0.012 CID_154699678 | CID_154699678 | |
| 0.002 | 0.1 | 0.013 | Purinergic P2 agonist | 0.013 0.012 CID_154699678 | CID_154699678 | |
| 0.051 | 0.169 | 0.116 | Topoisomerase II inhibitor | 0.116 0.071 CID_154699678 | CID_154699678 | |
| 0.007 | 0.146 | 0.016 | Adenosine A3 receptor agonist | 0.016 0.014 CID_154699678 | CID_154699678 | |
| 0.119 | 0.309 | 0.369 | Peptidyltransferase inhibitor | 0.369 0.009 CID_154699678 | CID_154699678 | |
| 0.033 | 0.223 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.013 CID_154699678 | CID_154699678 | |
| 0.044 | 0.258 | 0.352 | Lipid peroxidase inhibitor | 0.352 0.013 CID_154699678 | CID_154699678 | |
| 0.006 | 0.233 | 0.018 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.018 0.007 CID_154699678 | CID_154699678 | |
| 0.037 | 0.297 | 0.222 | Thrombolytic | 0.222 0.042 CID_154699678 | CID_154699678 | |
| 0.128 | 0.403 | 0.428 | Apoptosis agonist | 0.428 0.101 CID_154699678 | CID_154699678 | |
| 0.012 | 0.298 | 0.318 | Selectin antagonist | 0.318 0.005 CID_154699678 | CID_154699678 | |
| 0.013 | 0.312 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.057 0.016 CID_154699678 | CID_154699678 | |
| 0.003 | 0.319 | 0.016 | Retinoic acid receptor gamma antagonist | 0.016 0.005 CID_154699678 | CID_154699678 | |
| 0.039 | 0.376 | 0.141 | Cell adhesion inhibitor | 0.141 0.052 CID_154699678 | CID_154699678 | |
| 0.012 | 0.356 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 CID_154699678 | CID_154699678 | |
| 0.004 | 0.361 | 0.018 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.018 0.016 CID_154699678 | CID_154699678 | |
| 0.048 | 0.42 | 0.164 | Tumour necrosis factor alpha release inhibitor | 0.164 0.141 CID_154699678 | CID_154699678 | |
| 0.018 | 0.395 | 0.211 | Topoisomerase I inhibitor | 0.211 0.024 CID_154699678 | CID_154699678 | |
| 0.078 | 0.47 | 0.227 | Sodium/bile acid cotransporter inhibitor | 0.227 0.154 CID_154699678 | CID_154699678 | |
| 0.004 | 0.398 | 0.025 | Retinoic acid receptor antagonist | 0.025 0.008 CID_154699678 | CID_154699678 | |
| 0.066 | 0.533 | 0.158 | Catenin beta inhibitor | 0.158 0.088 CID_154699678 | CID_154699678 | |
| 0.035 | 0.503 | 0.457 | Antioxidant | 0.457 0.025 CID_154699678 | CID_154699678 | |
| 0.017 | 0.513 | 0.105 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 CID_154699678 | CID_154699678 | |
| 0.025 | 0.523 | 0.386 | Free radical scavenger | 0.386 0.031 CID_154699678 | CID_154699678 | |
| 0.009 | 0.517 | 0.089 | Neuraminidase (influenza) inhibitor | 0.089 0.02 CID_154699678 | CID_154699678 | |
| 0.041 | 0.556 | 0.408 | Immunosuppressant | 0.408 0.059 CID_154699678 | CID_154699678 | |
| 0.021 | 0.556 | 0.486 | Angiogenesis stimulant | 0.486 0.013 CID_154699678 | CID_154699678 | |
| 0.039 | 0.579 | 0.138 | NOS3 expression enhancer | 0.138 0.086 CID_154699678 | CID_154699678 | |
| 0.005 | 0.552 | 0.078 | Neuraminidase inhibitor | 0.078 0.027 CID_154699678 | CID_154699678 | |
| 0.005 | 0.552 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 CID_154699678 | CID_154699678 | |
| 0.037 | 0.59 | 0.312 | Hepatoprotectant | 0.312 0.026 CID_154699678 | CID_154699678 | |
| 0.041 | 0.636 | 0.547 | Immunomodulator | 0.547 0.017 CID_154699678 | CID_154699678 | |
| 0.003 | 0.608 | 0.054 | Squalene synthetase inhibitor | 0.054 0.013 CID_154699678 | CID_154699678 | |
| 0.012 | 0.628 | 0.113 | Uric acid excretion stimulant | 0.113 0.042 CID_154699678 | CID_154699678 | |
| 0.045 | 0.687 | 0.196 | Apoptosis antagonist | 0.196 0.184 CID_154699678 | CID_154699678 | |
| 0.004 | 0.676 | 0.166 | Antineoplastic antibiotic | 0.166 0.027 CID_154699678 | CID_154699678 | |
| 0.015 | 0.688 | 0.208 | Nitric oxide antagonist | 0.208 0.064 CID_154699678 | CID_154699678 | |
| 0.009 | 0.689 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 CID_154699678 | CID_154699678 | |
| 0.003 | 0.731 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.015 CID_154699678 | CID_154699678 | |
| 0.009 | 0.738 | 0.153 | Platelet antagonist | 0.153 0.142 CID_154699678 | CID_154699678 | |
| 0.008 | 0.74 | 0.124 | Anticoagulant | 0.124 0.108 CID_154699678 | CID_154699678 | |
| 0.009 | 0.748 | 0.074 | Glucose-6-phosphate translocase inhibitor | 0.074 0.014 CID_154699678 | CID_154699678 | |
| 0.02 | 0.779 | 0.066 | Lipocortins synthesis agonist | 0.066 0.026 CID_154699678 | CID_154699678 | |
| 0.004 | 0.767 | 0.043 | Microtubule stabilization | 0.043 0.037 CID_154699678 | CID_154699678 | |
| 0.015 | 0.792 | 0.325 | Platelet adhesion inhibitor | 0.325 0.026 CID_154699678 | CID_154699678 | |
| 0.003 | 0.834 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.023 CID_154699678 | CID_154699678 | |
| 0.012 | 0.875 | 0.409 | Hypoglycemic | 0.409 0.026 CID_154699678 | CID_154699678 | |
| 0.009 | 0.875 | 0.613 | Cyclophilin D inhibitor | 0.613 0.025 CID_154699678 | CID_154699678 | |
| 0.005 | 0.896 | 0.062 | Protein 50S ribosomal subunit inhibitor | 0.062 0.029 CID_154699678 | CID_154699678 | |
| 0.005 | 0.903 | 0.188 | Hypolipemic | 0.188 0.103 CID_154699678 | CID_154699678 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |